Literature DB >> 8299712

The labelling of proliferating cells by Ki67 and MIB-1 antibodies depends on the binding of a nuclear protein to the DNA.

F Lopez1, F Belloc, F Lacombe, P Dumain, J Reiffers, P Bernard, M R Boisseau.   

Abstract

The antigen Ki-67 Ag, regarded as a marker for proliferating cells, was identified as a protein(s) (pKi-67) which can exist free or associated with DNA as evidenced by DNA digestion of cells before or after immunolabeling with Ki-67. The dual nature of this antigen was also supported by reconstitution of Ki-67 Ag from purified DNA and nuclear proteins extracted from the K562 cell line. The immunoreactivity of the resulting complexes was examined in solution using Ki-67 and MIB-1 antibodies. The interaction between Ki-67 or MIB-1 antibodies and pKi-67 was enhanced in the presence of undegraded ds DNA, indicating that ds DNA modulates the conformation of pKi-67 and that the altered conformation of pKi-67 is more reactive than the pure protein to both Ki-67 and MIB-1 antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8299712     DOI: 10.1006/excr.1994.1022

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Three-dimensional organization of pKi-67: a comparative fluorescence and electron tomography study using FluoroNanogold.

Authors:  Thierry Cheutin; Marie-Françoise O'Donohue; Adrien Beorchia; Christophe Klein; Hervé Kaplan; Dominique Ploton
Journal:  J Histochem Cytochem       Date:  2003-11       Impact factor: 2.479

2.  Ki67: from antibody to molecule to understanding?

Authors:  W Ross; P A Hall
Journal:  Clin Mol Pathol       Date:  1995-06

3.  Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.

Authors:  P Rudolph; U Kellner; A Chassevent; F Collin; F Bonichon; R Parwaresch; J M Coindre
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Prognostic significance of the proliferative activity in neuroblastoma.

Authors:  P Rudolph; T Lappe; B Hero; F Berthold; R Parwaresch; D Harms; D Schmidt
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

5.  Effect of Ribonuclease A and Deoxyribonuclease I on Immunostaining of Ki-67 in Cultured Melanoma Cells.

Authors:  Jamal Benfares; Agnés Le Tourneau; Josée Audouin; György Szekeres
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

6.  Potential doubling time and tumour doubling time in meningiomas and neurinomas.

Authors:  S Nakasu; Y Nakasu; M Nakajima; M Yokoyama; M Matsuda; J Handa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

7.  Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.

Authors:  Paulo Henrique Aguiar; Ana Maria Tsanaclis; Oswaldo Inácio Tella; José Pindaro Plese
Journal:  Neurosurg Rev       Date:  2003-04-08       Impact factor: 3.042

8.  Proliferative activity of microvascular cells in glioblastomas does not correlate with time to recurrence.

Authors:  Michael A Kern; Klaus D Feisel; Michael Friese; Ralf-Ingo Ernestus; Roland Schröder
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

9.  PDX:PBX complexes are required for normal proliferation of pancreatic cells during development.

Authors:  S Dutta; M Gannon; B Peers; C Wright; S Bonner-Weir; M Montminy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

10.  Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder Cancer.

Authors:  Hui Guo; Faping Li; Weiguo Xu; Jinjin Chen; Yuchuan Hou; Chunxi Wang; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2018-03-27       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.